首页 › 多发性骨髓瘤 › 佛罗里达州 › Plantation
Plantation FL 多发性骨髓瘤临床试验
5项针对 多发性骨髓瘤的研究正在 Plantation及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
招募中3 期
- BRCR Global, Plantation
- BRCR Medical Center Inc, Plantation
- Brcr Medical Center, Inc., Plantation
- 以及另外 1 项
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
招募中3 期
- Sylvester Comprehensive Cancer Center - Plantation, Plantation
A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
招募中1 期
- Florida Clinical Trials Group, Plantation
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
招募中2 期
- University of Miami/Sylvester Cancer Institute - Plantation, Plantation
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
招募中3 期
- Sylvester Comprehensive Cancer Center - Plantation, Plantation
其他城市的 多发性骨髓瘤试验
- New York City, NY59 项研究
- Boston, MA45 项研究
- Atlanta, GA42 项研究
- Houston, TX39 项研究
- Durham, NC36 项研究
- Nashville, TN31 项研究
- Denver, CO26 项研究
- St. Louis, MO26 项研究
- Rochester, MN25 项研究
- Columbus, OH25 项研究
- Chicago, IL24 项研究
- Milwaukee, WI23 项研究
Plantation的其他研究
- 乳腺癌14 项研究
- 非小细胞肺癌13 项研究
- 狼疮7 项研究
- 类风湿关节炎7 项研究
- 癌症（所有类型）7 项研究
- 肺癌6 项研究
- 转移性癌症6 项研究
- 头颈鳞状细胞癌5 项研究
- 小细胞肺癌5 项研究
- 前列腺癌5 项研究
- 结直肠癌5 项研究
- 三阴性乳腺癌4 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年11月15日。每项研究自行设定入选标准，由研究团队决定谁能参与。